Cargando…
The role of TP53 gain-of-function mutation in multifocal glioblastoma
PURPOSE: The phenotypic and genotypic landscapes in multifocal glioblastoma (MF GBM) cases can vary greatly among lesions. In a MF GBM patient, the rapid development of a secondary lesion was investigated to determine if a unique genetic signature could account for the apparent increased malignancy...
Autores principales: | Olafson, Lauren R., Gunawardena, Manuri, Nixdorf, Sheri, McDonald, Kerrie L., Rapkins, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075848/ https://www.ncbi.nlm.nih.gov/pubmed/32002804 http://dx.doi.org/10.1007/s11060-019-03318-5 |
Ejemplares similares
-
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
por: Jue, Toni Rose, et al.
Publicado: (2017) -
Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies
por: Kurdi, Maher, et al.
Publicado: (2021) -
TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy
por: Noor, Humaira, et al.
Publicado: (2021) -
The role of cytoreductive surgery in multifocal/multicentric glioblastomas
por: Dimov, Diyan, et al.
Publicado: (2023) -
A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype
por: Jue, Toni Rose, et al.
Publicado: (2019)